Key result
Medicaid coverage is linked to an ~8% lower likelihood of receiving aspirin post-MI.
Why the study?
Do neighborhood socioeconomic status and Medicaid coverage influence the receipt of evidence-based pharmacologic treatments post-MI?
Population
9,608 MI events in the ARIC community surveillance study (1993-2002)
Comparison
Low census tract-level neighborhood household… vs High nINC and no Medicaid coverage
Design
Cohort
Follow-up
During hospitalization or at discharge
Authors
Loading...
Highlights disparities in post-MI care for Medicaid patients; leaves open neighborhood SES effects and need for prospective studies.
Observational (n=9,608)
Yes
Do neighborhood socioeconomic status and Medicaid coverage influence the receipt of evidence-based pharmacologic treatments post-MI?
Relative Risk: 0.92 (95% CI 0.87–0.98)
Absolute Event Rate: 75.5% vs 88.8%
Lower neighborhood income and Medicaid coverage are associated with disparities in the receipt of evidence-based medical therapies following myocardial infarction.
Foraker et al. (2010) conducted an observational in Myocardial infarction (n=9,608). Medicaid coverage vs. No Medicaid coverage was evaluated on Receipt of aspirin during hospitalization or at discharge (PR 0.92, 95% CI 0.87-0.98). Patients with Medicaid coverage were significantly less likely to receive aspirin post-myocardial infarction compared to patients without Medicaid coverage (PR 0.92).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: